Alterity Therapeutics (ATHE) EPS (Basic) (2016 - 2020)
Alterity Therapeutics (ATHE) recorded quarterly EPS (Basic) of $0.0 in Q4 2020, down 99.92% quarter-over-quarter from $0.01 in Q2 2020, and up 100.0% on a YoY basis from $0.0 in Q1 2020.
Alterity Therapeutics (ATHE) EPS (Basic) (2016 - 2020) Analysis & Trends
Alterity Therapeutics' EPS (Basic) history runs 5 years deep, the most recent figure standing at $0.0 for Q4 2020.
- In Q4 2020, EPS (Basic) rose 100.0% year-over-year to $0.0; the TTM figure through Jun 2022 stood at $0.0 (up 100.0% YoY), while the FY2025 annual figure was -$0.12, up 64.49% from the prior year.
- EPS (Basic) was $0.0 for Q4 2020 at Alterity Therapeutics, down from $0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.01 in Q2 2020 to a low of -$8.68 in Q4 2019.
- Historically, EPS (Basic) has averaged -$3.33 across 5 years, with a median of -$2.98 in 2016.
- The sharpest annual moves came in 2019 and 2020: EPS (Basic) plunged 151.86% in 2019, then soared 100.0% in 2020.
- A 5-year view of EPS (Basic) shows it stood at -$2.52 in 2016, then sank by 111.23% to -$5.32 in 2017, then soared by 35.24% to -$3.45 in 2018, then slumped by 151.86% to -$8.68 in 2019, then jumped by 100.0% to $0.0 in 2020.
- The last three EPS (Basic) figures came in at $0.0 (Q4 2020), $0.01 (Q2 2020), and -$8.68 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.00 |
| Jun 30, 2020 | 0.01 |
| Dec 31, 2019 | -8.68 |
| Dec 31, 2018 | -3.45 |
| Dec 31, 2017 | -5.32 |
| Dec 31, 2016 | -2.52 |